Nephros wins FDA nod for chronic renal failure device

The FDA has granted Nephros 510(k) clearance for its Hemodiafiltration system, which is used to help treat patients with chronic renal failure. The device features the company's OLpur MD220 Hemodiafilter and OLpur H2H Hemodiafiltration module.

View Full Article in:

Nephros, Inc. Receives 510(k) Clearance for Hemodiafiltration System - Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC